Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/01/2011WO2011148243A1 Extended release formulation of pramipexole
12/01/2011WO2011148208A1 8-hydroxy-quinoline derivatives
12/01/2011WO2011148207A1 Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents
12/01/2011WO2011148203A1 Formulation based on sulpiride and a synergistic homeopathic composition for treatment of depressive syndrome
12/01/2011WO2011148193A1 Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions
12/01/2011WO2011148124A1 Novel iridium/rhodium anti-cancer compounds
12/01/2011WO2011148116A2 Modified hyaluronic acid, method for manufacturing same and uses thereof
12/01/2011WO2011148014A1 Use of oxaloacetate in the treatment of ischaemia
12/01/2011WO2011147999A1 Compound inhibiting activation of the enzyme erk1/2 for use in the treatment of neurogenerative illnesses
12/01/2011WO2011147964A1 Formulation containing azelaic acid and having a pigment addition
12/01/2011WO2011147951A1 Cycloamino derivatives as gpr119 antagonists
12/01/2011WO2011147933A1 Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that transcur through a deficit of maturation of the cornified envelope
12/01/2011WO2011147910A1 Pyrazole compounds as sigma receptor inhibitors
12/01/2011WO2011147810A1 THE USE OF sGC STIMULATORS, sGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS (SSc).
12/01/2011WO2011147809A1 Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
12/01/2011WO2011147780A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
12/01/2011WO2011147772A1 Ccr2 receptor antagonists
12/01/2011WO2011147764A1 Thieno (2, 3b) pyrazine compounds as b - raf inhibitors
12/01/2011WO2011147753A1 Antiviral activity of novel bicyclic heterocycles
12/01/2011WO2011147589A1 Neramexane for the treatment or prevention of inner ear disorders
12/01/2011WO2011147588A1 Compositions for use in genetic disorders comprising 4-phenyl- butyric acid and its salts
12/01/2011WO2011147587A1 Compositions for use in cardiovascular diseases comprising 4 - phenyl - butyric acid and its salts
12/01/2011WO2011147586A1 Compositions for use in neurological or neurodegenerative diseases with a genetic disorder background comprising 4-phenyl-butyric acid and its salts
12/01/2011WO2011147585A1 Compositions for use in the treatment of immune diseases, comprising 4 - phenyl -butyric acid and its salts
12/01/2011WO2011147584A1 Compositions for use in genetic disorders causative for cystic fibrosis comprising 4-phenyl-butyric acid and its salts
12/01/2011WO2011147536A2 Topical pharmaceutical compositions
12/01/2011WO2011147528A1 Biguanide compounds and its use for treating cancer
12/01/2011WO2011147471A1 Antidementia oral pharmaceutical solutions
12/01/2011WO2011147330A1 Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate
12/01/2011WO2011147326A1 Phenanthroindolizidine alkaloid organic acid salt derivatives and medicinal use thereof
12/01/2011WO2011147320A1 B cell activating factor antagonist and preparation method and use thereof
12/01/2011WO2011147316A1 Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof
12/01/2011WO2011147313A1 Levoisovalerylspiramycin i, ii or iii, preparations, preparation methods and uses thereof
12/01/2011WO2011147311A1 Hydroxy propanediol derivatives, their preparative method, pharmaceutical compositions and use
12/01/2011WO2011147296A1 Pyrazole derivatives
12/01/2011WO2011147281A1 Aqueous formulation of vitamins and preparation method thereof
12/01/2011WO2011147280A1 Injection of enrofloxacin and producing method thereof
12/01/2011WO2011147259A1 Novel benzoxazine oxazolidinone compounds, preparation methods and uses thereof
12/01/2011WO2011147254A1 Phenylbutyryl curcumin derivatives and uses for preparing anti-tumor drugs thereof
12/01/2011WO2011147252A1 Compound preparation and its uses for prevention and treatment of hearing impairment
12/01/2011WO2011147207A1 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF
12/01/2011WO2011147199A1 Compounds and methods for treating viral infections
12/01/2011WO2011147198A1 Compounds and methods for treatment of proliferative diseases
12/01/2011WO2011147193A1 High-affinity nucleic acid aptamers against sclerostin protein
12/01/2011WO2011147185A1 Immunosuppressant j2 - sodium alginate microsphere, preparation method and use thereof
12/01/2011WO2011147175A1 PREPARATION OF MICROVESICLE-siRNA COMPLEXES AND USE THEREOF IN AIDS TREATMENT
12/01/2011WO2011147066A1 Arylamino purine derivatives, preparation method and pharmaceutical use thereof
12/01/2011WO2011147038A1 Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
12/01/2011WO2011147034A1 Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof
12/01/2011WO2011147025A1 Controlled release dosage form comprising quetiapine
12/01/2011WO2011147012A1 Compositions comprising botanicals, including the use and method of use thereof
12/01/2011WO2011146981A1 Anti-diabetic compositions and methods
12/01/2011WO2011146954A1 Process for the preparation of pleuromutilins
12/01/2011WO2011127058A8 Biomarkers for mdm2 inhibitors for use in treating disease
12/01/2011WO2011127019A3 Methods for treating respiratory viral infection
12/01/2011WO2011126842A3 Targeting micrornas for the treatment of cardiac disorders
12/01/2011WO2011126385A3 Assay system
12/01/2011WO2011126352A3 Anti-tuberculosis preparation based on an inclusion complex of cyclodextrin with rifampicin and a method for the preparation thereof
12/01/2011WO2011121475A3 Modified release dosage form comprising desvenlafaxine or salts thereof
12/01/2011WO2011120930A8 Method for stimulating the reproductive capacity in a bull, and composition for stimulating the reproductive capacity in a bull
12/01/2011WO2011115700A3 Emollient foams for treatment of seborrheic dermatitis
12/01/2011WO2011113892A3 Combined use of phospholipid and sulfate groups-carrying polysaccharides for inhibiting metastatic spread
12/01/2011WO2011112953A3 Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers
12/01/2011WO2011105901A3 Antagonists of complement component 9 (c9) and uses thereof
12/01/2011WO2011104161A9 Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti - inflammatory agent for the treatment of inflammation and pain in the veterinary field
12/01/2011WO2011102754A3 Carbon nanocluster sulfo-adduct, method for producing same and use thereof
12/01/2011WO2011102668A3 Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives
12/01/2011WO2011100769A3 Kinase modulators for the treatment of cancer
12/01/2011WO2011100642A3 Method for treating hematological cancers
12/01/2011WO2011097522A3 Combination methods for treatment of disease
12/01/2011WO2011097336A3 Highly selective 5-ht(2c) receptor agonists having antagonist activity at the 5-ht(2b) receptor
12/01/2011WO2011094657A3 Additives for chlorine dioxide-containing compositions
12/01/2011WO2011094260A3 Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
12/01/2011WO2011093600A3 Skin wound healing agent containing decursin and decursinol angelate
12/01/2011WO2011093524A9 Di - substituted pyridine derivatives as anticancers
12/01/2011WO2011091213A3 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
12/01/2011WO2011090316A3 Novel pyrazinone derivatives having an apoptosis-inducing activity, and pharmaceutical compositions comprising same
12/01/2011WO2011090283A3 Composition containing inhibitors of the expression or activity of sh3rf2 for preventing or treating cancer
12/01/2011WO2011088020A9 Modified saponins for the treatment of fungal infections
12/01/2011WO2011087343A3 Composition for treating cancer related to an hpv infection
12/01/2011WO2011086575A4 A pharmaceutical composition for treatment respiratory tract infections
12/01/2011WO2011085356A3 Povidone-iodine and sucrose wound healing dressing
12/01/2011WO2011084898A3 Enhanced bone healing
12/01/2011WO2011081488A3 Composition for treatment of obesity using wheat bran extract or active ingredient isolated therefrom
12/01/2011WO2011081415A3 Sirna for inhibiting c-met expression and an anti-cancer composition comprising the same
12/01/2011WO2011079279A3 Nanoconjugates and nanoconjugate formulations
12/01/2011WO2011079213A9 Treating critically ill patients with intravenous ibuprofen
12/01/2011WO2011077406A3 Process for preparing tablets comprising 5- hydroxytryptophan and tryptophan
12/01/2011WO2011076843A3 Combination therapy for copd
12/01/2011WO2011076842A3 Aerosol formulation for copd
12/01/2011WO2011076840A3 Aerosol formulation for copd
12/01/2011WO2011054929A3 Method for producing triptolide
12/01/2011WO2011016043A3 Antibiotic drug delivery and potentiation
12/01/2011WO2010146551A3 Orally disintegrating compositions comprising antihypertensive agents
12/01/2011WO2010133609A3 Composition comprising oil drops
12/01/2011WO2009134524A9 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
12/01/2011US20110295190 Wound Dressing and Methods of Making and Using the Same
12/01/2011US20110295189 Iontophoretic preparation for treatment of breast cancer and/or mastitis
12/01/2011US20110295185 Intestinal Brake Inducing Intraluminal Therapeutic Substance Eluting Devices and Methods
12/01/2011US20110295014 Process for production of piperidine derivatives